QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
17.10
-0.82 (-4.58%)
At close: Mar 13, 2026, 4:00 PM EDT
17.28
+0.18 (1.05%)
After-hours: Mar 13, 2026, 7:38 PM EDT
QuidelOrtho Revenue
In the year 2025, QuidelOrtho had annual revenue of $2.73B, down -1.89%. QuidelOrtho had revenue of $723.60M in the quarter ending December 28, 2025, with 2.23% growth.
Revenue (ttm)
$2.73B
Revenue Growth
-1.89%
P/S Ratio
0.43
Revenue / Employee
$420,031
Employees
6,500
Market Cap
1.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2025 | 2.73B | -52.70M | -1.89% |
| Dec 29, 2024 | 2.78B | -214.90M | -7.17% |
| Dec 31, 2023 | 3.00B | -268.20M | -8.21% |
| Jan 1, 2023 | 3.27B | 1.57B | 92.28% |
| Jan 2, 2022 | 1.70B | 36.90M | 2.22% |
| Jan 3, 2021 | 1.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.24B |
| Enovis | 2.25B |
| CONMED | 1.37B |
| Tandem Diabetes Care | 1.01B |
| Inspire Medical Systems | 911.98M |
| NovoCure | 655.35M |
| UFP Technologies | 602.80M |
| Artivion | 441.33M |
QDEL News
- 22 days ago - Faster Cardiac Answers with High‑Sensitivity Troponin - PRNewsWire
- 23 days ago - QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference - PRNewsWire
- 4 weeks ago - QuidelOrtho Corporation (QDEL) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results - PRNewsWire
- 5 weeks ago - QuidelOrtho Receives Excellence Services Label in EMEA and Two Stevie® Awards - PRNewsWire
- 7 weeks ago - Strengthening the blood supply: Awareness, challenges and donor impact - PRNewsWire
- 7 weeks ago - QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results - PRNewsWire
- 3 months ago - Innovating Diagnostics and What's Next - PRNewsWire